News
Madrigal Pharmaceuticals, Inc. (NASDAQ:MDGL), a biopharmaceutical company focused on delivering novel therapeutics for metabolic dysfunction-associated ...
Aligos Therapeutics, Inc. (Nasdaq: ALGS) a clinical stage biopharmaceutical company focused on improving patient outcomes through best-in-class therapies for liver and viral diseases, today announced ...
USA News Group News Commentary Issued on behalf of Oncolytics Biotech Inc. VANCOUVER, BC, June 18, 2025 /PRNewswire/ -- USA ...
Individuals with metabolic dysfunction‐associated steatotic liver disease experience a higher burden of multimorbidity, with ...
The company is positioning BE-Smart for near-term commercialization, targeting the $10 billion esophageal disease testing ...
Sana Makbul reveals her battle with liver cirrhosis, stemming from an autoimmune disorder diagnosed after initial signs in ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results